Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Total Debt (2016 - 2017)

Historic Total Debt for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $20.1 million.

  • Bone Biologics' Total Debt rose 3433.86% to $20.1 million in Q3 2017 from the same period last year, while for Sep 2017 it was $20.1 million, marking a year-over-year increase of 3433.86%. This contributed to the annual value of $8.8 million for FY2016, which is N/A changed from last year.
  • Per Bone Biologics' latest filing, its Total Debt stood at $20.1 million for Q3 2017, which was up 3433.86% from $19.1 million recorded in Q2 2017.
  • Bone Biologics' 5-year Total Debt high stood at $20.1 million for Q3 2017, and its period low was $8.8 million during Q4 2016.